PathAI Revenue and Competitors

Claim your profile

Boston, MA USA

Location

#4458

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • PathAI's estimated annual revenue is currently $93.1M per year.(i)
  • PathAI received $11.0M in venture funding in November 2017.
  • PathAI's estimated revenue per employee is $217,000
  • PathAI's total funding is $255.2M.

Employee Data

  • PathAI has 429 Employees.(i)
  • PathAI grew their employee count by 36% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-99%N/AN/A
#2
$3.1M20233%N/AN/A
#3
$21.5M13918%$351MN/A
#4
$18M1165%$312.8MN/A
#5
$235M418-23%$340.9MN/A
#6
$2.2M3417%N/AN/A
#7
$6M40-9%$176.5MN/A
#8
$109.4M70614%N/AN/A
#9
$6.2M40233%N/AN/A
#10
$1.9M12-20%N/AN/A

PathAI's mission is to advance medicine with intelligent pathology. PathAI's platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses. Research and Drug Development Solutions PathAI's deep-learning solutions drive discovery and predictive diagnostics in drug-development. PathAI's technology accelerates R&D efforts and brings standardization to all phases of the drug development pipeline. Clinical Solutions PathAI is developing clinical decision support tools to improve the clinical workflow and bring increased efficiency, standardization, and clinical insights to diagnostic pathology. Global Health Solutions PathAI is working towards improving health around the globe, by building machine learning applications to provide pathologic diagnoses at a low cost in developing nations. PathAI's goal is to make an enduring impact on patient care by helping hundreds of millions of people receive accurate diagnoses and effective therapies.

keywords:saas

$255.2M

Total Funding

429

Number of Employees

$93.1M

Revenue (est)

36%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PathAI News

2022-04-06 - PathAI Announces Upcoming Presentations at the 2022 American ...

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the...

2022-04-06 - PathAI and GlaxoSmithKline Partner to Accelerate Research and ...

– The partnership will combine GSK and PathAI's AI and platform engineering teams to scale algorithm development and enable the discovery of new...

2022-03-30 - PathAI and GlaxoSmithKline Sign Multi-Year Agreement to ...

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI's platform promises substantial improvements to the...

2021-06-24 - PathAI to Present Machine Learning-Based Drug Development Tool For Assessment of Nonalcoholic Steatohepatitis Histopathology at the International Liver Congress 2021

BOSTON, June 24, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology, today announced the presentation of new data describing improved digital assessment of nonalcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). These results will ...

2021-06-04 - PathAI and Genentech Present on AI-Powered Pathologic Response Assessment in NSCLC at the American Society of Clinical Oncology Virtual Scientific Program 2021

BOSTON, June 4, 2021 /PRNewswire/ -- PathAI, a global provider of AI-powered technology applied to pathology, today announced that new data highlighting the application of its ML-based PathR algorithm to clinical trials as an aid to pathologists will be presented in the American Society of Cli ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$79M42911%$39.1M
#2
$214.5M42944%N/A
#3
$145.8M4320%N/A
#4
$146.5M434N/AN/A
#5
$124M4370%N/A

PathAI Funding

DateAmountRoundLead InvestorsReference
2017-11-06$11.0MAGeneral Catalyst PartnersArticle